Femasys Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FEMY research report →
About the company
Femasys Inc. , a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering.
- CEO
- Kathy Lee-Sepsick
- IPO
- 2021
- Employees
- 69
- HQ
- Suwanee, GA, US
Price Chart
- Market Cap
- $12.59M
- P/E
- -0.65
- P/S
- 5.30
- P/B
- 1.91
- EV/EBITDA
- -1.26
- Div Yield
- 0.00%
- Gross Margin
- 53.12%
- Op Margin
- -687.93%
- Net Margin
- -521.78%
- ROE
- -258.08%
- ROIC
- -118.32%
- Revenue
- $2.29M · 40.77%
- Net Income
- $-18,627,887 · 1.00%
- EPS
- $-9.40 · 44.05%
- Op Income
- $-17,588,669
- FCF YoY
- 4.90%
- 52W High
- $22.20
- 52W Low
- $3.50
- 50D MA
- $6.44
- 200D MA
- $10.82
- Beta
- -2.13
- Avg Volume
- 61.51K
Get TickerSpark's AI analysis on FEMY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 30, 26 | Canning John Charles | other | 150,000 |
| Mar 30, 26 | Canning John Charles | other | 0 |
| Mar 19, 26 | Lee-Sepsick Kathy | other | 68,244 |
| Mar 19, 26 | Elefant Dov | other | 34,122 |
| Mar 19, 26 | Eichenbaum Kenneth D. | other | 102,366 |
| Mar 19, 26 | Larsen Charles | other | 34,122 |
| Mar 18, 26 | Eichenbaum Kenneth D. | other | 0 |
| Nov 7, 25 | Eichenbaum Kenneth D. | other | 102,366 |
| Nov 7, 25 | Eichenbaum Kenneth D. | other | 102,366 |
| Nov 7, 25 | Eichenbaum Kenneth D. | other | 102,366 |
Our FEMY coverage
Recent articles, reports, and earnings notes.
No research on FEMY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FEMY report →Similar companies
Peers in the same neighborhood.